Neuroprotective effects of quercetin in animal models of neurodegenerative diseases: A systematic review and meta-analysis.
Quercetin shows promise in improving cognitive performance and modulating neuroprotective pathways in animal models, but its clinical relevance needs further investigation.
Where it sits
this study against the rest of the adamax corpusSummary and findings
This study evaluated the impact of quercetin on neurodegenerative biomarkers and cognitive performance in animal models. A total of 19 studies were included in the analysis, focusing on various outcomes such as inflammatory cytokines and cognitive tests. Quercetin was found to improve cognitive performance and modulate several neuroprotective pathways.
Abstract
Neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease are characterized by progressive neuronal loss driven by oxidative stress and inflammation. Quercetin, a dietary flavonoid with established antioxidant and anti-inflammatory properties, has emerged as a potential neuroprotective agent. This study aimed to quantitatively synthesize and evaluate preclinical evidence regarding the impact of quercetin on neurodegenerative biomarkers and cognitive performance. A comprehensive literature search was conducted using PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL). After strict screening and selection, 19 studies were included. These evaluated the effects of quercetin on: Morris water maze (MWM) performance; inflammatory cytokines - including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-10 (IL-10); the oxidative stress marker malondialdehyde (MDA); antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), and glutathione (GSH); brain-derived neurotrophic factor (BDNF); and acetylcholinesterase (AChE) activity. Subgroup analyses based on quercetin dose (<100 mg kg⁻¹ versus ≥100 mg kg⁻¹) and treatment duration (<28 versus ≥28 days) were performed. Quercetin improved cognitive performance significantly by reducing escape latency and improving performance on memory retention indicators. It decreased pro-inflammatory cytokines (IL-6 and TNF-α), increased IL-10, enhanced antioxidant enzyme activity (CAT, SOD, and GSH), reduced MDA levels, up-regulated BDNF, and inhibited AChE. Subgroup analyses suggested that quercetin exerted stronger effects at lower doses and with longer treatment durations, although not all subgroup differences were statistically significant. Quercetin demonstrated multi-targeted neuroprotective effects in animal models, improving cognition and modulating inflammatory, oxidative, and neurotrophic pathways. These findings support the potential of quercetin as a therapeutic agent for neurodegenerative diseases, warranting further clinical investigation. © 2026 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Background
This paper addresses the neuroprotective effects of quercetin in the context of neurodegenerative diseases like Alzheimer's and Parkinson's. Prior research has established that oxidative stress and inflammation contribute to neuronal loss in these conditions. Understanding the potential role of quercetin could provide insights into new therapeutic strategies.
Methods
The study conducted a systematic review and meta-analysis of 19 preclinical studies. It evaluated the effects of quercetin on various outcomes, including cognitive performance and inflammatory markers. Subgroup analyses were performed based on quercetin dose and treatment duration.
Results
Quercetin was found to significantly improve cognitive performance by reducing escape latency. It also decreased IL-6 and TNF-α levels while increasing IL-10. Additionally, quercetin enhanced antioxidant enzyme activity and reduced MDA levels.
Interpretation
While the findings suggest that quercetin has multiple neuroprotective effects, the clinical significance of these results remains uncertain. The effect sizes observed may not be clinically meaningful, and the reliance on animal models limits the applicability to human conditions. Further research is needed to confirm these effects in clinical settings.
Key findings
- Quercetin improved cognitive performance significantly by reducing escape latency.
- Quercetin decreased pro-inflammatory cytokines IL-6 and TNF-α.
- Quercetin increased IL-10 levels.
- Quercetin enhanced antioxidant enzyme activity (CAT, SOD, GSH).
- Quercetin reduced malondialdehyde (MDA) levels.
- Quercetin inhibited acetylcholinesterase (AChE) activity.
Limitations
- Based on animal models, which may not directly translate to humans.
- Not all subgroup differences were statistically significant.
- Potential publication bias in included studies.
- Limited information on long-term effects.
- No human data reported.